273 related articles for article (PubMed ID: 19387532)
21. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
22. A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.
Wang F; Numata K; Chuma M; Miwa H; Moriya S; Ogushi K; Okada M; Otani M; Inayama Y; Maeda S
J Med Ultrason (2001); 2021 Apr; 48(2):215-224. PubMed ID: 33721130
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.
Mita K; Kim SR; Kudo M; Imoto S; Nakajima T; Ando K; Fukuda K; Matsuoka T; Maekawa Y; Hayashi Y
World J Gastroenterol; 2010 Sep; 16(33):4187-92. PubMed ID: 20806437
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
27. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
Kudo M; Hatanaka K; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
[TBL] [Abstract][Full Text] [Related]
29. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.
Lee J; Jeong WK; Lim HK; Kim AY
J Ultrasound Med; 2018 Jun; 37(6):1473-1480. PubMed ID: 29159819
[TBL] [Abstract][Full Text] [Related]
30. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
31. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Kudo M; Hatanaka K; Inoue T; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of impaired phagocytic function of Kupffer cells in an obstructive cholangitis rat model using superparamagnetic iron oxide MRI and contrast-enhanced ultrasound.
Lee JH; Kim JH; Lee S; Han JK
Acta Radiol; 2019 Apr; 60(4):407-414. PubMed ID: 30724596
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation.
Ishigami K; Tajima T; Fujita N; Nishie A; Asayama Y; Kakihara D; Nakayama T; Okamoto D; Taketomi A; Shirabe K; Honda H
Eur J Radiol; 2011 Dec; 80(3):e293-8. PubMed ID: 21288675
[TBL] [Abstract][Full Text] [Related]
34. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Contrast-Enhanced Ultrasound by Sonazoid in the Early Diagnosis of Biliary Atresia: An Experimental Study of Rats With Bile Duct Ligation.
Wang Y; Xie X; Cao Q; Xie W; Chen D; Zhang X; Guo Y; Zhou L
Ultrasound Med Biol; 2019 Oct; 45(10):2767-2776. PubMed ID: 31345651
[TBL] [Abstract][Full Text] [Related]
36. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
[TBL] [Abstract][Full Text] [Related]
37. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
[TBL] [Abstract][Full Text] [Related]
38. Two patterns of contrast-enhanced ultrasonography with Sonazoid
Sugihara T; Koda M; Okamoto T; Miyoshi K; Matono T; Isomoto H
J Med Ultrason (2001); 2018 Apr; 45(2):319-323. PubMed ID: 28815352
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
Kobayashi T; Aikata H; Hatooka M; Morio K; Morio R; Kan H; Fujino H; Fukuhara T; Masaki K; Ohno A; Naeshiro N; Nakahara T; Honda Y; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Takahashi S; Chayama K
Eur Radiol; 2015 Nov; 25(11):3272-81. PubMed ID: 26037713
[TBL] [Abstract][Full Text] [Related]
40. Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule.
Takeshita K; Nagashima I; Frui S; Takada K; Yamauchi T; Harasawa A; Oba H; Kohtake H; Tanaka H; Suzuki S
J Comput Assist Tomogr; 2002; 26(3):451-5. PubMed ID: 12016379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
